Hasil Pencarian  ::  Simpan CSV :: Kembali

Abstrak :
[Aspergillus flavus UICC 360 merupakan fungi yang mampu menghasilkan senyawa metabolit sekunder berupa lovastatin. Penelitian bertujuan untuk mengetahui pengaruh variasi konsentrasi urea terhadap kemampuan Aspergillus flavus UICC 360 dalam menghasilkan lovastatin. Proses fermentasi menggunakan konsentrasi inokulum Aspergillus flavus UICC 360 sebesar 1,96% (v/v) dalam medium Czapek?s Dox Broth (CDB) modifikasi dengan variasi konsentrasi urea (0 mM, 33 mM, 42 mM, 50 mM, 58 mM, dan 67 mM) dan inkubasi selama 7 hari pada suhu ruang (27--300C) dengan kecepatan agitasi 90 rpm. Ekstrak hasil fermentasi dalam etil asetat diuji terhadap Candida albicans UICC Y-29 menggunakan metode difusi agar cara cakram. Ekstrak hasil fermentasi dari konsentrasi urea 42 mM mempunyai indeks penghambatan rata-rata tertinggi sebesar 0,54 ± 0,15. Hasil Kromatografi Lapis Tipis (KLT) menunjukkan bahwa nilai Rf ekstrak hasil fermentasi dari konsentrasi urea 42 mM sama dengan lovastatin standar, yaitu 0,42 yang mengindikasikan ekstrak mengandung lovastatin. Uji Least Significant Difference (LSD) (P < 0,05) menunjukkan terdapat perbedaan nyata variasi konsentrasi urea terhadap kemampuan Aspergillus flavus UICC 360 dalam menghasilkan lovastatin. Hal tersebut menunjukkan bahwa pemberian variasi konsentrasi urea berpengaruh terhadap kemampuan Aspergillus flavus UICC 360 dalam menghasilkan lovastatin.;Aspergillus flavus UICC 360 is capable of producing secondary metabolites such as lovastatin. The study aims to determine the effect of variations of urea concentration on the ability of Aspergillus flavus UICC 360 to produce lovastatin. The fermentation process using 1.96% (v/v) inoculum concentration of Aspergillus flavus UICC 360 in the Czapek?s Dox Broth (CDB) medium modified with urea concentration variations (0 mM, 33 mM, 42 mM, 50 mM, 58 mM, and 67 mM) and incubated for 7 days at room temperature (27--30 °C) with agitation speed of 90 rpm. Ethyl acetate extracts were tested against Candida albicans UICC Y-29 using agar disc diffusion method. The extract from fermentation medium of 42 mM urea has the highest average of inhibition index of 0.54 ± 0.15. Results of Thin Layer Chromatography (TLC) showed that the extract from fermentation medium of 42 mM urea has the same Rf value with lovastatin standard Rf 0.42 which indicated that the extract contained lovastatin. Least Significant Difference (LSD) test showed that there were significant difference in the urea concentration variation in the ability of Aspergillus flavus UICC 360 to produce lovastatin. It shows that variation of urea concentrations affect the ability of Aspergillus flavus UICC 360 to produce lovastatin., Aspergillus flavus UICC 360 is capable of producing secondary metabolites such as lovastatin. The study aims to determine the effect of variations of urea concentration on the ability of Aspergillus flavus UICC 360 to produce lovastatin. The fermentation process using 1.96% (v/v) inoculum concentration of Aspergillus flavus UICC 360 in the Czapek’s Dox Broth (CDB) medium modified with urea concentration variations (0 mM, 33 mM, 42 mM, 50 mM, 58 mM, and 67 mM) and incubated for 7 days at room temperature (27--30 °C) with agitation speed of 90 rpm. Ethyl acetate extracts were tested against Candida albicans UICC Y-29 using agar disc diffusion method. The extract from fermentation medium of 42 mM urea has the highest average of inhibition index of 0.54 ± 0.15. Results of Thin Layer Chromatography (TLC) showed that the extract from fermentation medium of 42 mM urea has the same Rf value with lovastatin standard Rf 0.42 which indicated that the extract contained lovastatin. Least Significant Difference (LSD) test showed that there were significant difference in the urea concentration variation in the ability of Aspergillus flavus UICC 360 to produce lovastatin. It shows that variation of urea concentrations affect the ability of Aspergillus flavus UICC 360 to produce lovastatin.]

Abstrak :
[Aspergillus flavus UICC 360 merupakan fungi yang mampu menghasilkan senyawa metabolit sekunder berupa lovastatin. Penelitian bertujuan untuk mengetahui pengaruh variasi konsentrasi urea terhadap kemampuan Aspergillus flavus UICC 360 dalam menghasilkan lovastatin. Proses fermentasi menggunakan konsentrasi inokulum Aspergillus flavus UICC 360 sebesar 1,96% (v/v) dalam medium Czapek’s Dox Broth (CDB) modifikasi dengan variasi konsentrasi urea (0 mM, 33 mM, 42 mM, 50 mM, 58 mM, dan 67 mM) dan inkubasi selama 7 hari pada suhu ruang (27--300C) dengan kecepatan agitasi 90 rpm. Ekstrak hasil fermentasi dalam etil asetat diuji terhadap Candida albicans UICC Y-29 menggunakan metode difusi agar cara cakram. Ekstrak hasil fermentasi dari konsentrasi urea 42 mM mempunyai indeks penghambatan rata-rata tertinggi sebesar 0,54 ± 0,15. Hasil Kromatografi Lapis Tipis (KLT) menunjukkan bahwa nilai Rf ekstrak hasil fermentasi dari konsentrasi urea 42 mM sama dengan lovastatin standar, yaitu 0,42 yang mengindikasikan ekstrak mengandung lovastatin. Uji Least Significant Difference (LSD) (P < 0,05) menunjukkan terdapat perbedaan nyata variasi konsentrasi urea terhadap kemampuan Aspergillus flavus UICC 360 dalam menghasilkan lovastatin. Hal tersebut menunjukkan bahwa pemberian variasi konsentrasi urea berpengaruh terhadap kemampuan Aspergillus flavus UICC 360 dalam menghasilkan lovastatin.;Aspergillus flavus UICC 360 is capable of producing secondary metabolites such as lovastatin. The study aims to determine the effect of variations of urea concentration on the ability of Aspergillus flavus UICC 360 to produce lovastatin. The fermentation process using 1.96% (v/v) inoculum concentration of Aspergillus flavus UICC 360 in the Czapek’s Dox Broth (CDB) medium modified with urea concentration variations (0 mM, 33 mM, 42 mM, 50 mM, 58 mM, and 67 mM) and incubated for 7 days at room temperature (27--30 °C) with agitation speed of 90 rpm. Ethyl acetate extracts were tested against Candida albicans UICC Y-29 using agar disc diffusion method. The extract from fermentation medium of 42 mM urea has the highest average of inhibition index of 0.54 ± 0.15. Results of Thin Layer Chromatography (TLC) showed that the extract from fermentation medium of 42 mM urea has the same Rf value with lovastatin standard Rf 0.42 which indicated that the extract contained lovastatin. Least Significant Difference (LSD) test showed that there were significant differences in the urea concentration variation in the ability of Aspergillus flavus UICC 360 to produce lovastatin. It shows that variation of urea concentrations affect the ability of Aspergillus flavus UICC 360 to produce lovastatin., Aspergillus flavus UICC 360 is capable of producing secondary metabolites such as lovastatin. The study aims to determine the effect of variations of urea concentration on the ability of Aspergillus flavus UICC 360 to produce lovastatin. The fermentation process using 1.96% (v/v) inoculum concentration of Aspergillus flavus UICC 360 in the Czapek’s Dox Broth (CDB) medium modified with urea concentration variations (0 mM, 33 mM, 42 mM, 50 mM, 58 mM, and 67 mM) and incubated for 7 days at room temperature (27--30 °C) with agitation speed of 90 rpm. Ethyl acetate extracts were tested against Candida albicans UICC Y-29 using agar disc diffusion method. The extract from fermentation medium of 42 mM urea has the highest average of inhibition index of 0.54 ± 0.15. Results of Thin Layer Chromatography (TLC) showed that the extract from fermentation medium of 42 mM urea has the same Rf value with lovastatin standard Rf 0.42 which indicated that the extract contained lovastatin. Least Significant Difference (LSD) test showed that there were significant differences in the urea concentration variation in the ability of Aspergillus flavus UICC 360 to produce lovastatin. It shows that variation of urea concentrations affect the ability of Aspergillus flavus UICC 360 to produce lovastatin.]

Abstrak :
Aspergillus flavus UICC 360 has been reported to produce lovastatin. This research was carried out to determine the effect of concentration variation of glucose technical grade on the ability of A. flavus UICC 360 to produce lovastatin. The fermentation process was carried out using inoculum 2% (v/v) modified Czapek's Dox Broth (CDB). Variation of glucose technical grade concentration used were 0 g/L, 5 g/L, 10 g/L, 15 g/L, 20 g/L, 25 g/L, 30 g/L and 35 g/L. Fermentation was carried out for 6 days at room temperature (27--30ºC) with agitation speed of 90 rpm. Extraction of lovastatin was done with ethyl acetate solvent. The extract was assayed by disk diffusion method against Candida albicans UICC Y-29. The results revealed that the fermentation extract on glucose technical grade at 15 g/L showed the highest inhibition index of 0.77 ± 0.09. Analysis using Least Significant Difference (LSD) (P < 0.05) showed there was significant difference on the ability of A. flavus UICC 360 to produce lovastatin at different glucose technical grade concentration. High Performance of Liquid Chromatography (HPLC) showed that concentration of 15 g/L glucose technical grade had the same retention time with standard lovastatin at 4.52 minutes and 54.2 mg/L concentration.

Abstrak :
ABSTRAK
Telah dilakukan penelitian untuk mengetahui pengaruh variasi konsentrasi molase terhadap kemampuan Aspergillus flavus UICC 360 dalam menghasilkan lovastatin. Proses fermentasi dilakukan dalam medium Czapek?s Dox Broth (CDB) modifikasi dengan perlakuan variasi konsentrasi molase (0 g/L, 55 g/L, 60 g/L, 65 g/L, 70 g/L, 75 g/L, 80 g/L, dan 85 g/L) selama 7 hari pada suhu ruang (27--30˚C) dengan kecepatan agitasi 90 rpm. Ekstraksi senyawa lovastatin dilakukan dengan pelarut etil asetat. Pengujian ekstrak lovastatin dilakukan dengan metode difusi agar cara cakram terhadap Candida albicans UICC Y-29. Hasil penelitian menunjukkan bahwa nilai rata-rata indeks penghambatan tertinggi sebesar 0,49 ± 0,07 diperoleh dari ekstrak lovastatin dengan perlakuan molase 70 g/L. Analisis uji Least Significant Difference (LSD) (P < 0,05) menunjukkan bahwa terdapat pengaruh nyata perlakuan konsentrasi molase terhadap kemampuan A. flavus UICC 360 dalam menghasilkan lovastatin. Analisis kualitatif dan kuantitatif lovastatin dengan Kromatografi Cair Kinerja Tinggi (KCKT) menunjukkan keberadaan senyawa lovastatin pada perlakuan molase 70 g/L dengan waktu retensi sama dengan lovastatin standar, yaitu 4,5 menit dengan kadar 1,1 mg/L.

---

ABSTRACT
This research was carried out to determine the effect of concentration variation of molasses on the ability of Aspergillus flavus UICC 360 to produce lovastatin. The fermentation process was carried out using Czapek's Dox Broth (CDB) containing variation of molasses concentrations (0 g /L, 55 g /L, 60 g/L, 65 g/L, 70 g/L, 75 g/L, 80 g/L, and 85 g/L) for 7 days at room temperature (27--30˚C) with agitation speed of 90 rpm. Extraction of lovastatin was done with ethyl acetate solvent. Lovastatin extracts were tested using agar disc diffusion method against Candida albicans UICC Y-29. The result revealed that the highest inhibition index of 0.49 ± 0.07 was obtained from lovastatin extracts-treated molasses 70 g/L. Analysis using Least Significant Difference (LSD) (P < 0.05) indicated that there was significant difference on the ability of A. flavus UICC 360 to produce lovastatin at different molasses concentration. Qualitative and quantitative analysis of lovastatin using High Performance Liquid Chromatography (HPLC) proved that lovastatin was present at 70 g/L molasses with the same retention time to lovastatin standard, which was 4.5 minutes, at concentration of 1.1 mg/L.